Follow
David M. Mauger
David M. Mauger
Director of Data Science, Arrakis Therapeutics
Verified email at arrakistx.com
Title
Cited by
Cited by
Year
mRNA structure regulates protein expression through changes in functional half-life
DM Mauger, BJ Cabral, V Presnyak, SV Su, DW Reid, B Goodman, K Link, ...
Proceedings of the National Academy of Sciences 116 (48), 24075-24083, 2019
4272019
Exploring RNA structural codes with SHAPE chemistry
KM Weeks, DM Mauger
Accounts of chemical research 44 (12), 1280-1291, 2011
1672011
hnRNP H and hnRNP F complex with Fox2 to silence fibroblast growth factor receptor 2 exon IIIc
DM Mauger, C Lin, MA Garcia-Blanco
Molecular and cellular biology 28 (17), 5403-5419, 2008
1602008
A requirement for the Saccharomyces cerevisiae Paf1 complex in snoRNA 3′ end formation
KE Sheldon, DM Mauger, KM Arndt
Molecular cell 20 (2), 225-236, 2005
1412005
Functionally conserved architecture of hepatitis C virus RNA genomes
DM Mauger, M Golden, D Yamane, S Williford, SM Lemon, DP Martin, ...
Proceedings of the National Academy of Sciences 112 (12), 3692-3697, 2015
1292015
MicroRNAs enable mRNA therapeutics to selectively program cancer cells to self-destruct
R Jain, JP Frederick, EY Huang, KE Burke, DM Mauger, EA Andrianova, ...
Nucleic acid therapeutics 28 (5), 285-296, 2018
1242018
The genetic code as expressed through relationships between mRNA structure and protein function
DM Mauger, NA Siegfried, KM Weeks
FEBS letters 587 (8), 1180-1188, 2013
642013
IFNL3 mRNA structure is remodeled by a functional non-coding polymorphism associated with hepatitis C virus clearance
YF Lu, DM Mauger, DB Goldstein, TJ Urban, KM Weeks, SS Bradrick
Scientific reports 5 (1), 16037, 2015
612015
Characterization of the intronic splicing silencers flanking FGFR2 exon IIIb
EJ Wagner, AP Baraniak, OM Sessions, D Mauger, E Moskowitz, ...
Journal of Biological Chemistry 280 (14), 14017-14027, 2005
542005
Fas-activated serine/threonine phosphoprotein (FAST) is a regulator of alternative splicing
M Simarro, D Mauger, K Rhee, MA Pujana, NL Kedersha, S Yamasaki, ...
Proceedings of the National Academy of Sciences 104 (27), 11370-11375, 2007
512007
Polynucleotide secondary structure
D Mauger, I McFadyen, V Presnyak
US Patent App. 16/483,012, 2020
422020
Analysis of RNA nearest neighbor parameters reveals interdependencies and quantifies the uncertainty in RNA secondary structure prediction
J Zuber, BJ Cabral, I McFadyen, DM Mauger, DH Mathews
Rna 24 (11), 1568-1582, 2018
332018
Toward global RNA structure analysis
DM Mauger, KM Weeks
Nature biotechnology 28 (11), 1178-1179, 2010
272010
TIA nuclear proteins regulate the alternate splicing of lysyl hydroxylase 2
HN Yeowell, LC Walker, DM Mauger, P Seth, MA Garcia-Blanco
Journal of investigative dermatology 129 (6), 1402-1411, 2009
212009
The identification of factors regulating the alternative splicing of the FGFR2 transcript in epithelial cells
DM Mauger
Duke University, 2007
12007
High fidelity in vitro transcription
D Mauger, V Presnyak, AE Rabideau, I McFadyen
US Patent 11,851,694, 2023
2023
Polynucleotide secondary structure
D Mauger, I McFadyen, V Presnyak
US Patent App. 18/093,119, 2023
2023
Nuclear proteins TIA and PTB regulate the alternately-spliced long transcript of lysyl hydroxylase 2 that is increased in scleroderma
P Seth, LC Walker, DM Mauger, MA Garcia-Blanco, HN Yeowell
JOURNAL OF INVESTIGATIVE DERMATOLOGY 128, S121-S121, 2008
2008
Factors affecting splicing of scleroderma-associated LH2 mRNA
P Seth, LC Walker, DM Mauger, MA Garcia-Blanco, HN Yeowell
Matrix Biology, 60, 2008
2008
Identification of elements regulating the alternate splicing of Lysyl Hydroxylase 2 (LH2) using a functional 353bp LH2 minigene construct
HN Yeowell, LC Walker, MA Overstreet, A Siddiqui, DM Mauger, ...
JOURNAL OF INVESTIGATIVE DERMATOLOGY 126, 77-77, 2006
2006
The system can't perform the operation now. Try again later.
Articles 1–20